Chief Operating Officer, Takeda Pharmaceutical Company Limited
30+ presentations will be given at the 2019 meeting. Over two days, leaders in biopharmaceutical production will elaborate on their research into innovative manufacturing strategies for complex biotherapeutics and advanced therapies by exploiting new technologies. There will be a focus on overcoming bottlenecks within the manufacturing process, efficiency and maintaining high-quality standards. As well as assessing the manufacturing processes and regulatory challenges for biologics, the congress also features a track dedicated to the complex manufacturing of cell and gene therapies.
2019 Featured speakers – meet all the speakers here
Professor, Biotechnology, Austrian Center of Industrial Biotechnology, University of natural resources and science
This exceptional speaker panel, assembled from leaders in biopharmaceutical drug production will ensure that you will walk away from the conference with these key takeaways.
Table 1: CMO management – challenges & insights for outsourcing complex biologics
Led by: JENS LOHRMANN, Disease Area, Head Oncology, Technical R&D, Novartis
Table 2: Sharing Practices/Preferences with Sterile Filter Integrity Testing of Drug Product
Led by: KIRSTEN STRAHLENDORF, Senior Scientist, BioProcess R&D Formulation and Stability, Sanofi Pasteur